drugset / Trial / NCT02737033

Effects of 800mg of Rhodiola Rosea in Attention in Adults With Attention-Deficit/Hyperactivity Disorder

NCT02737033

Phase 4 Unknown 60 enrolled Hospital de Clinicas de Porto Alegre
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluates the use of Rhodiola rosea in the attention of adults with Attention Deficit/Hyperactivity Disorder (ADHD). Half of participants will receive Rhodiola rosea 800mg, while the other half will receive 800mg of placebo.

Timeline

Start
2016-04
Primary completion
2021-03
Completion
2021-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Rhodiola Traditional medicine (herbal / TCM) 800 mg